2CUREX APS has a total of 12 patent applications. Its first patent ever was published in 2005. It filed its patents most often in Australia, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are PROXIMA CONCEPTS LTD, INNOVA BIOSCIENCES LTD and FUNDACIO PRIVADA INST DINVESTIGACIO ONCOLOGICA DE VALL HEBRON.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | United States | 2 | |
#5 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Analysing materials | |
#3 | Medical preparations | |
#4 | Therapeutic chemical compounds | |
#5 | Measuring microorganism processes | |
#6 | Combinatorial chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Thastrup Ole | 12 |
#2 | Hagel Grith | 9 |
#3 | Norrild Jens | 3 |
#4 | Norrild Jens Chr | 1 |
#5 | Diness Frederik | 1 |
#6 | St Hilaire Phaedria Marie | 1 |
#7 | Kaznelson Dorte Wissing | 1 |
#8 | Nielsen Thomas Eiland | 1 |
#9 | Meldal Morten | 1 |
Publication | Filing date | Title |
---|---|---|
AU2015283320A1 | Identifying compounds modifying a cellular phenotype | |
WO2007009457A2 | Identification of protein ligands modifying a cellular response | |
EP1888619A2 | Compounds modifying apoptosis | |
EP1761783A2 | Identification of compounds modifying a cellular response |